These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 33897423)

  • 1. 1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection.
    Chen RH; Yang LJ; Hamdoun S; Chung SK; Lam CW; Zhang KX; Guo X; Xia C; Law BYK; Wong VKW
    Front Pharmacol; 2021; 12():634176. PubMed ID: 33897423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding.
    Yang LJ; Chen RH; Hamdoun S; Coghi P; Ng JPL; Zhang DW; Guo X; Xia C; Law BYK; Wong VKW
    Phytomedicine; 2021 Jul; 87():153591. PubMed ID: 34029937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.
    Barh D; Tiwari S; Silva Andrade B; Giovanetti M; Almeida Costa E; Kumavath R; Ghosh P; Góes-Neto A; Carlos Junior Alcantara L; Azevedo V
    F1000Res; 2020; 9():576. PubMed ID: 32802318
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2.
    Chen X; Wang Z; Wang J; Yao Y; Wang Q; Huang J; Xiang X; Zhou Y; Xue Y; Li Y; Gao X; Wang L; Chu M; Wang Y
    Front Pharmacol; 2022; 13():940628. PubMed ID: 36003511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms.
    Xu C; Wang A; Geng K; Honnen W; Wang X; Bruiners N; Singh S; Ferrara F; D'Angelo S; Bradbury ARM; Gennaro ML; Liu D; Pinter A; Chang TL
    Viruses; 2021 May; 13(6):. PubMed ID: 34064066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contact residue contributions to interaction energies between SARS-CoV-1 spike proteins and human ACE2 receptors.
    Rodriguez JH; Gupta A
    Sci Rep; 2021 Jan; 11(1):1156. PubMed ID: 33441985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding.
    Yip KM; Lee KM; Ng TB; Xu S; Yung KKL; Qu S; Cheung AKL; Sze SCW
    Chin Med; 2022 Jul; 17(1):88. PubMed ID: 35897044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2.
    Miluzio A; Cuomo A; Cordiglieri C; Donnici L; Pesce E; Bombaci M; Conti M; Fasciani A; Terracciano L; Manganaro L; Toccafondi M; Scagliola A; Oliveto S; Ricciardi S; Grifantini R; De Francesco R; Abrignani S; Manfrini N; Biffo S
    EBioMedicine; 2023 Jan; 87():104390. PubMed ID: 36584595
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Huang X; Pearce R; Zhang Y
    Aging (Albany NY); 2020 Jun; 12(12):11263-11276. PubMed ID: 32544884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2.
    Wang X; Yang C; Sun Y; Sui X; Zhu T; Wang Q; Wang S; Yang J; Yang W; Liu F; Zhang M; Wang Y; Luo Y
    Environ Int; 2021 Feb; 147():106361. PubMed ID: 33401173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor.
    Hameed NS; Arif IS; Al-Sudani BT
    J Adv Pharm Technol Res; 2023; 14(3):185-190. PubMed ID: 37692001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of molecular interaction, physicochemical parameters and conserved pattern of SARS-CoV-2 Spike RBD and hACE2: in silico and molecular dynamics approach.
    Chakraborty C; Sharma AR; Mallick B; Bhattacharya M; Sharma G; Lee SS
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1708-1723. PubMed ID: 33629340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging of composition variations of SARS-CoV-2 spike protein and human ACE2 contribute to the level of infection:
    AlGhamdi NA; Alsuwat HS; Borgio JF; AbdulAzeez S
    J Biomol Struct Dyn; 2022 Apr; 40(6):2635-2646. PubMed ID: 33138699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.
    Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X
    Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomechanical Characterization of SARS-CoV-2 Spike RBD and Human ACE2 Protein-Protein Interaction.
    Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF
    bioRxiv; 2020 Jul; ():. PubMed ID: 32766576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein.
    Rabbani G; Ahn SN; Kwon H; Ahmad K; Choi I
    Biochem Biophys Rep; 2021 Dec; 28():101170. PubMed ID: 34778573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2.
    Sakib MMH; Nishat AA; Islam MT; Raihan Uddin MA; Iqbal MS; Bin Hossen FF; Ahmed MI; Bashir MS; Hossain T; Tohura US; Saif SI; Jui NR; Alam M; Islam MA; Hasan MM; Sufian MA; Ali MA; Islam R; Hossain MA; Halim MA
    Comput Biol Med; 2021 Sep; 136():104759. PubMed ID: 34403938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics analysis predicts ritonavir and naloxegol strongly block the SARS-CoV-2 spike protein-hACE2 binding.
    Bagheri M; Niavarani A
    J Biomol Struct Dyn; 2022 Mar; 40(4):1597-1606. PubMed ID: 33030105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library.
    Bell BN; Powell AE; Rodriguez C; Cochran JR; Kim PS
    Protein Sci; 2021 Apr; 30(4):716-727. PubMed ID: 33586288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.